PEAK6 Investments’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
PIP
KGAMU
WPM
BCM
PEAK6 Investments's CDLX Position: Q2 2022 in Review
PEAK6 Investments sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 607 shares — an estimated $334K sold.
PEAK6 Investments first reported a position in CDLX in Q2 2021 and held it in 3 quarters. The position peaked at $874K in Q2 2021. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.
- PEAK6 Investments reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
- PEAK6 Investments sold 607 Cardlytics shares in Q2 2022, an estimated $334K.
- PEAK6 Investments first reported a position in Cardlytics in Q2 2021 and held it in 3 quarters.
- PEAK6 Investments's Cardlytics position peaked at $874K in Q2 2021.
- 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.
Based on PEAK6 Investments's 13F filing for Q2 2022, filed 12 Aug 2022.